23 unknown. 23 Phase 2, 5 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 23 | Unknown 23 |
| Phase 1 | 5 | Unknown 5 |
| Phase 3 | 4 | Unknown 4 |
Follow Therapeutics: new trials by email Literature Review of Therapeutics trials Research Report on Therapeutics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke Adaptive Servoventilation (ASV) therapy, Best medical treatment - Stroke, Sleep Apnea | Phase 2 | Unknown | Philips Portuguesa S.A. | 90 | 2024-02-27 | 2024-08-12 |
| Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma HAIC, Sintilimab, Bevacizumab Biosimilar IBI305 - Hepatocellular Carcinoma | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 43 | 2022-11-02 | 2022-11-15 |
| Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). Atezolizumab - Squamous Cell Carcinoma, Urinary Tract Cancer | Phase 2 | Unknown | University Hospital Southampton NHS Foundation Trust | 36 | 2022-05-30 | 2022-10-03 |
| Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks., Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. - Buruli Ulcer | Phase 2 | Unknown | Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) | 140 | 2021-12-01 | 2024-05-16 |
| Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD Autologous BM-MSC, Sham - Intervertebral Disc Degeneration, Chronic Low-back Pain | Phase 2 | Unknown | Fondazione Policlinico Universitario Campus Bio-Medico | 52 | 2021-03-22 | 2025-05-25 |
| Positioning Imatinib for Pulmonary Arterial Hypertension Imatinib Mesylate - Pulmonary Arterial Hypertension | Phase 2 | Unknown | Imperial College London | 17 | 2021-01-20 | 2023-10-10 |
| Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19. COVID-19 convalescent plasma, Anti-COVID-19 human immunoglobulin, Standard (specific) therapy for COVID-19 - Coronavirus Disease 2019 (COVID-19) | Phase 2 / Phase 3 | Unknown | Lifefactors Zona Franca, SAS | 75 | 2020-09-01 | 2020-07-10 |
| A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC) Treatment with Poziotinib - Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma | Phase 2 | Unknown | Yonsei University | 49 | 2019-04-01 | 2019-02-22 |
| Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis Arsenic Keratosis lesion or nodular size observation after 12 weeks of therapy with solasodine ointment - Keratotic Nodular Size | Phase 2 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 20 | 2018-09-23 | 2021-01-05 |
| Efficacy and Safety of Rapamycin to Complex Vascular Anomalies in Pediatric Patients Treatment with oral rapmycin - Vascular Anomalies | Phase 2 / Phase 3 | Unknown | Zhujiang Hospital | 30 | 2017-12-01 | 2021-11-10 |
| Cognitive-Behavioral Rehabilitation for Bipolar Disorder Cognitive Behavioral Rehabilitation, Treatment as Usual - Bipolar Disorder | Phase 1 / Phase 2 | Unknown | University of Sao Paulo | 60 | 2016-03-01 | 2022-05-26 |
| Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy HM781-36B - HNSCC | Phase 2 | Unknown | Yonsei University | 49 | 2014-08-01 | 2019-03-18 |
| Chinese Medicine on Deferring Dialysis Initiation CM therapies, CKD-related management - End-Stage Renal Disease | Phase 1 / Phase 2 | Unknown | Guangdong Provincial Hospital of Traditional Chinese Medicine | 875 | 2014-07-01 | 2019-12-26 |
| Working Memory Training in Adults With Substance Abuse and Executive Function Deficits. Computerized Cogmed working memory training, Treatment as usual - Substance Abuse, Executive Dysfunction | Phase 2 | Unknown | Örebro Läns Landsting | 100 | 2014-01-01 | 2015-10-23 |
| Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation 1-year treatment with icotinib, 2-year treatment with icotinib - Non-small-cell Lung Cancer | Phase 2 | Unknown | Betta Pharmaceuticals Co., Ltd. | 120 | 2013-08-01 | 2015-05-22 |
| Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection TwHF, placebo treatment - Human Immunodeficiency Virus | Phase 1 / Phase 2 | Unknown | Beijing 302 Hospital | 60 | 2012-06-01 | 2015-08-17 |
| Dentin Treatments for Restorations of Cervical Lesions Non-Carious Treatment of Dentin Surface, Dentin Surface, Treatment - Adhesion | Phase 2 / Phase 3 | Unknown | Federal University of Pelotas | 28 | 2011-03-01 | 2015-05-05 |
| Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders Family psychoeducational therapy plus TAU, Treatment as usual - Pervasive Developmental Disorder | Phase 2 / Phase 3 | Unknown | Nagoya City University | 74 | 2010-09-01 | 2011-01-19 |
| First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer carboplatin, vinorelbine tartrate, neuromuscular electrical stimulation - Chemotherapeutic Agent Toxicity, Fatigue | Phase 2 | Unknown | Wales Cancer Trials Unit | 52 | 2009-09-01 | 2011-08-08 |
| T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant adoptive immunotherapy, alemtuzumab, in vitro-treated peripheral blood lymphocyte therapy - Graft Versus Host Disease, Nonneoplastic Condition | Phase 2 | Unknown | University Hospital Birmingham | 78 | 2009-09-01 | 2013-08-26 |
Showing 20 of 23. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (2) · Depression (2) · Substance-Related Disorders (2) · Acquired Immunodeficiency Syndrome (1) · Antisocial Personality Disorder (1) · Anxiety Disorders (1) · Bipolar Disorder (1) · Brain Neoplasms (1) · Buruli Ulcer (1) · COVID-19 (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Squamous Cell (1) · Child Development Disorders, Pervasive (1) · Coronavirus Infections (1) · Cytomegalovirus Infections (1)
Yonsei University (2) · Aposense Ltd. (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Beijing 302 Hospital (1) · Betta Pharmaceuticals Co., Ltd. (1) · Federal University of Pelotas (1) · Fondazione Policlinico Universitario Campus Bio-Medico (1) · Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) (1) · Guangdong Provincial Hospital of Traditional Chinese Medicine (1) · Imperial College London (1) · Lifefactors Zona Franca, SAS (1) · Nagoya City University (1) · Philips Portuguesa S.A. (1) · Seattle Children's Hospital (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (5) · United Kingdom (4) · United States (3) · South Korea (2) · Bangladesh (1) · Benin (1) · Brazil (1) · Colombia (1) · Italy (1) · Japan (1) · Portugal (1) · Sweden (1)
Andrew Wilcock, MD (1) · Beny Lafer, Professor (1) · Elizabeth McCauley, PHD (1) · Frederick Chen, MD (1) · Fu-Sheng Wang, Professor (1) · Gregory S. Brigham, Ph.D. (1) · Lars Kjellin, Docent (1) · Martin R Wilkins, MD, FRCP (1) · Masako Suzuki, MD (1) · Ping Li, PhD (1) · Rafael G Lund, PhD (1) · Simon Crabb (1)
PMID 12777656, PMID 12877429, PMID 15001284, PMID 15119583, PMID 15214887, PMID 15616839, PMID 16009415, PMID 16211552, PMID 17262225, PMID 17288322, PMID 18228057, PMID 18666493, PMID 18717178, PMID 19411519, PMID 19830963, PMID 20005565, PMID 20978636, PMID 21762980, PMID 23747824, PMID 23796341, PMID 24004965, PMID 24473714, PMID 25030060, PMID 25469648, PMID 27959686, PMID 28351410, PMID 32253318, PMID 34528763, PMID 35804454, PMID 37348348, PMID 37726695, PMID 38573915, PMID 42104494
2019 (1), K23DA021512 (1)